Your session is about to expire
← Back to Search
Reboocon Intuy Knee for Amputation
Study Summary
This trial aims to collect data from people with above-the-knee amputations to help doctors choose the best powered prosthetic knee for each patient. The data will be used to guide the prescription of
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Are there any vacancies available for patients to participate in this trial?
"Indeed, according to the information provided on clinicaltrials.gov, this trial is presently seeking eligible participants. The initial posting of the study occurred on September 12th, 2023, and it was most recently updated on December 22nd, 2023."
What is the current number of individuals enrolled in this medical study?
"Indeed, the information available on clinicaltrials.gov confirms that this study is actively seeking eligible participants. The trial was initially posted on September 12th, 2023 and underwent its most recent update on December 22nd, 2023. A total of 26 patients will be enrolled from a single designated site."
What are the specific objectives of this research study?
"The primary outcome measure for this clinical trial is the Activities-Specific Balance Confidence scale (ABC), which will be used to assess changes from baseline over the entire 9-month study period. Secondary outcomes include the Stair Assessment Index (SAI), a 14-level ordinal scale that evaluates an individual's ability to ascend and descend stairs, as well as the Timed Up and Go Test (TUG), which measures physical mobility by timing how long it takes for participants to rise from a chair, walk to a marker, turn around, return, and sit back down. Additionally, Patient Reported Outcomes Measures Information System - Physical Function (P"
Share this study with friends
Copy Link
Messenger